Is There Enough Technical Evidence to Go Long Peloton?
Let's see if it's time to jump back on the bike.
Looking at Bristol-Myers Again as the Quants Downgrade It
At current levels BMY is sort-of in no man's land - not bullish and not bearish.
Biotech CEL-SCI Needs More Base Building
Let's review the charts and indicators.
Dividend Hunters Will Like the Combination Found in Global Medical REIT Shares
More people seeking more healthcare and medical attention will create a rising tide for GMRE's addressable market.
Walgreens Boots Alliance Is Likely to Weaken Further
Let's check out the charts and indicators.
Emergent BioSolutions Turns Bearish, So Beware
A break in a key support level could precipitate further declines in the life sciences company's shares.
Centene Charts Remain Weak and Vulnerable
Let's review the charts and indicators.
Stopped Out on Johnson & Johnson but Willing to Buy it Lower
Stand aside for now.
Broad Rally, Vaccine Optimism, Johnson & Johnson, GameStop Roars, Trading Nvidia
The market's catalyst had everything to do with the virus... optimism that humankind might stuff that scourge back into Pandora's box.
Eli Lilly Is Poised for a Pullback Before Renewed Longer-Term Gains
Let's review the charts and indicators.